Protection of mRNA against nucleases in cytoplasmic extracts of mouse sarcoma ascites cells.
The mRNA present in extracts of mouse sarcoma 180 (S-180) ascites cells is relatively resistant to degradation when compared to added tracer ribosomal RNA. Deproteinized mRNA added to the extract is about as resistant as the endogenous mRNA, an indication that the protection is not due to any protein present in the endogenous mRNP structure. A major determinant of protection lies at the 5' end of RNA chains, where the presence of a triphosphate or a cap enhances the stability of mRNA transcripts. Addition of poly(A) to a capped transcript had little effect on stability. Stabilization by the cap structure is apparently not due to association of transcripts with a cap-binding protein. The discrimination in RNA decay rates appears to be based on interaction of the different RNA species with an exonuclease, which represents the predominant ribonuclease activity in the extract. Other major cytoplasmic nucleases are suppressed by an RNase inhibitor that is present in excess.
Coutts
M
M
Department of Biochemistry, Tufts University Health Sciences Schools, Boston, MA 02111.
Krowczynska
A
A
Brawerman
G
G
D000818:Animals; D002474:Cell-Free System; D005591:Chemical Fractionation; D003593:Cytoplasm / Q000201:enzymology; D005095:Exoribonucleases / Q000037:antagonists & inhibitors / Q000378:metabolism*; D051379:Mice; D012333:RNA, Messenger / Q000378:metabolism*; D012260:Ribonucleases / Q000037:antagonists & inhibitors; D012261:Ribonucleoproteins / Q000378:metabolism; D012510:Sarcoma 180 / Q000201:enzymology*
D012333:RNA, Messenger; D012261:Ribonucleoproteins; C026452:messenger ribonucleoprotein; D005095:Exoribonucleases; D012260:Ribonucleases